Deficiencies of molecules (shown with dashed lines) involved in...Figure 16.5. (A) Defects in cell adhesion disrupt the ability of leukocytes ...Figure 16.6. Complement cascade showing that deficiencies in early phase com...Figure 16.7. Structure of HIV‐1 showing two identical RNA strands (viral gen...Figure 16.8. The genes and proteins of HIV‐1. The HIV‐1 RNA genome is flanke...Figure 16.9. Correlation of B‐cell development with B‐cell malignancies.Figure 16.10. Some B‐cell neoplasms associated with translocations of genes ...Figure 16.11. Section through normal lymph node showing sites that become in...Figure 16.12. NF‐κB signaling pathways in B cells originating by stimulation...Figure 16.13. Correlation of T‐cell development with T‐cell malignancies.17 Chapter 17Figure 17.1. Situations of tissue transplantation.Figure 17.2. Direct and indirect recognition of alloantigens in grafted orga...Figure 17.3. Allograft activation of multiple CD4+ T cells leading to graft ...
18 Chapter 18Figure 18.2. Tumor infiltrating lymph node just within the lymph node capsul...Figure 18.1. Seminoma tumor (hematoxylin & eosin stain). Fibrous bands separ...Figure 18.3. A scanning electron micrograph showing an activated macrophage ...Figure 18.4. Interacting molecules on the surface of antigen‐presenting cell...Figure 18.5. General schema for using the adoptive transfer of naturally occ...Figure 18.6. CTLA4 and PD‐1 inhibition. Mechanism of CTLA‐4 and PD‐1 blockad...Figure 18.7. Generations of CAR‐T cells. All use scFv‐based receptor. First ...
19 Chapter 19Figure 19.1. Parabolic curve of the damage‐response framework. The y axis de...Figure 19.2. Potential outcomes of the interaction between a host and a micr...Figure 19.3. The relationship between the primary and secondary immune respo...Figure 19.4. Concentration of immunoglobulin in the serum during human devel...Figure 19.5. Serum concentration of human and equine IgG antitoxin following...Figure 19.6. The fate of human and equine IgG following administration into ...
20 Chapter 20Figure 20.1. Amount of label bound to antibody after incubation of constant ...Figure 20.2. Radioimmunoassay, based on the competition of nonlabeled and la...Figure 20.3. A representative ELISA using a well coated directly with antige...Figure 20.4. A schematic representation of a fluorescence‐activated cell sor...Figure 20.5. A schematic representation of the production of monoclonal anti...Figure 20.6. Assessment of apoptosis using a TUNEL assay.Figure 20.7. Tunel apoptosis assay. Cervical cancer cells (HeLA) grown in ce...Figure 20.8. A general procedure for producing transgenic mice.Figure 20.9. Microarray assay comparing samples of mRNA from lymphoid tumor ...
Guide
1 COVER
2 TABLE OF CONTENTS
Pages
1 iii
2 iv
3 v
4 x
5 xi
6 xii
7 xiii
8 xiv
9 xv
10 xvi
11 1
12 2
13 3
14 4
15 5
16 6
17 7
18 8
19 9
20 10
21 11
22 12
23 13
24 14
25 15
26 16
27 17
28 18
29 19
30 20
31 21
32 22
33 23
34 24
35 25
